Your browser doesn't support javascript.
loading
Author Correction: Chemoproteomic discovery of a covalent allosteric inhibitor of WRN helicase.
Baltgalvis, Kristen A; Lamb, Kelsey N; Symons, Kent T; Wu, Chu-Chiao; Hoffman, Melissa A; Snead, Aaron N; Song, Xiaodan; Glaza, Thomas; Kikuchi, Shota; Green, Jason C; Rogness, Donald C; Lam, Betty; Rodriguez-Aguirre, Maria E; Woody, David R; Eissler, Christie L; Rodiles, Socorro; Negron, Seth M; Bernard, Steffen M; Tran, Eileen; Pollock, Jonathan; Tabatabaei, Ali; Contreras, Victor; Williams, Heather N; Pastuszka, Martha K; Sigler, John J; Pettazzoni, Piergiorgio; Rudolph, Markus G; Classen, Moritz; Brugger, Doris; Claiborne, Christopher; Plancher, Jean-Marc; Cuartas, Isabel; Seoane, Joan; Burgess, Laurence E; Abraham, Robert T; Weinstein, David S; Simon, Gabriel M; Patricelli, Matthew P; Kinsella, Todd M.
Afiliação
  • Baltgalvis KA; Vividion Therapeutics, San Diego, CA, USA.
  • Lamb KN; Vividion Therapeutics, San Diego, CA, USA.
  • Symons KT; Vividion Therapeutics, San Diego, CA, USA.
  • Wu CC; Vividion Therapeutics, San Diego, CA, USA.
  • Hoffman MA; Vividion Therapeutics, San Diego, CA, USA.
  • Snead AN; Vividion Therapeutics, San Diego, CA, USA.
  • Song X; Vividion Therapeutics, San Diego, CA, USA.
  • Glaza T; Vividion Therapeutics, San Diego, CA, USA.
  • Kikuchi S; Vividion Therapeutics, San Diego, CA, USA.
  • Green JC; Vividion Therapeutics, San Diego, CA, USA.
  • Rogness DC; Vividion Therapeutics, San Diego, CA, USA.
  • Lam B; Vividion Therapeutics, San Diego, CA, USA.
  • Rodriguez-Aguirre ME; Vividion Therapeutics, San Diego, CA, USA.
  • Woody DR; Vividion Therapeutics, San Diego, CA, USA.
  • Eissler CL; Vividion Therapeutics, San Diego, CA, USA.
  • Rodiles S; Vividion Therapeutics, San Diego, CA, USA.
  • Negron SM; Vividion Therapeutics, San Diego, CA, USA.
  • Bernard SM; Vividion Therapeutics, San Diego, CA, USA.
  • Tran E; Vividion Therapeutics, San Diego, CA, USA.
  • Pollock J; Vividion Therapeutics, San Diego, CA, USA.
  • Tabatabaei A; Vividion Therapeutics, San Diego, CA, USA.
  • Contreras V; Vividion Therapeutics, San Diego, CA, USA.
  • Williams HN; Vividion Therapeutics, San Diego, CA, USA.
  • Pastuszka MK; Vividion Therapeutics, San Diego, CA, USA.
  • Sigler JJ; Vividion Therapeutics, San Diego, CA, USA.
  • Pettazzoni P; Pharma Research and Early Development pRED F. Hoffmann-La Roche, Ltd, Basel, Switzerland.
  • Rudolph MG; Pharma Research and Early Development pRED F. Hoffmann-La Roche, Ltd, Basel, Switzerland.
  • Classen M; Pharma Research and Early Development pRED F. Hoffmann-La Roche, Ltd, Basel, Switzerland.
  • Brugger D; Pharma Research and Early Development pRED F. Hoffmann-La Roche, Ltd, Basel, Switzerland.
  • Claiborne C; Pharma Research and Early Development pRED F. Hoffmann-La Roche, Ltd, Basel, Switzerland.
  • Plancher JM; Pharma Research and Early Development pRED F. Hoffmann-La Roche, Ltd, Basel, Switzerland.
  • Cuartas I; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, CIBERONC, Barcelona, Spain.
  • Seoane J; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, CIBERONC, Barcelona, Spain.
  • Burgess LE; Vividion Therapeutics, San Diego, CA, USA.
  • Abraham RT; Vividion Therapeutics, San Diego, CA, USA.
  • Weinstein DS; Odyssey Therapeutics, San Diego, CA, USA.
  • Simon GM; Vividion Therapeutics, San Diego, CA, USA.
  • Patricelli MP; Vividion Therapeutics, San Diego, CA, USA.
  • Kinsella TM; Vividion Therapeutics, San Diego, CA, USA. mattp@vividion.com.
Nature ; 631(8021): E12, 2024 Jul.
Article em En | MEDLINE | ID: mdl-38961306
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article